Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05701215
Title Venetoclax After TKI to Target Persisting Stem Cells in CML (VARIANT)
Acronym VARIANT
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Thomas Ernst, PD Dr. med.
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU

Facility Status City State Zip Country Details
Uniklinik der RWTH Aachen RECRUITING Aachen 52074 Germany Details
Universitätsklinikum Jena RECRUITING Jena 07747 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field